Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E2YV
|
|||
| Former ID |
DIB000160
|
|||
| Drug Name |
Glial cell line-derived neurotrophic factor protein
|
|||
| Synonyms |
BVF-014; Glial cell line-derived neurotrophic factor protein (CNS disease); Glial cell line-derived neurotrophic factor protein (CNS disease), Amgen; Glial cell line-derived neurotrophic factor protein (CNS disease), MedGenesis; Glial cell line-derived neurotrophic factor protein (CNS disease), MedGenesis/ Amgen; Glial cell-derived neurotrophic factor protein (CNS disease), Amgen/Biovail; Glial cell-derived neurotrophic factor protein (CNS disease), Amgen/Valeant
Click to Show/Hide
|
|||
| Indication | Central nervous system disease [ICD-11: 8A04-8D87; ICD-10: G00-G99] | Preclinical | [1] | |
| Company |
MedGenesis Therapeutix Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006587) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.